These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35537937)

  • 1. Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments.
    Elst L; Van Rompuy AS; Roussel E; Spans L; Vanden Bempt I; Necchi A; Ross J; Jacob JM; Baietti MF; Leucci E; Albersen M
    Eur Urol Focus; 2022 Nov; 8(6):1787-1794. PubMed ID: 35537937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
    Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI; Ryan CJ; McKay RR; Master VA; Bilen MA
    Cancer; 2023 Dec; 129(24):3884-3893. PubMed ID: 37565840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.
    Elst L; Philips G; Vandermaesen K; Bassez A; Lodi F; Vreeburg MTA; Brouwer OR; Schepers R; Van Brussel T; Mohanty SK; Parwani AV; Spans L; Vanden Bempt I; Jacomen G; Baldewijns M; Lambrechts D; Albersen M
    Eur Urol; 2024 Aug; 86(2):114-127. PubMed ID: 38670879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma.
    Zacharias NM; Segarra L; Akagi K; Fowlkes NW; Chen H; Alaniz A; de la Cerda C; Pesquera P; Xi Y; Wang J; Chahoud J; Lu X; Rao P; Martinez-Ferrer M; Pettaway CA
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma.
    Bandini M; Ross JS; Zhu Y; Ye DW; Ornellas AA; Watkin N; Ayres BA; Hakenberg OW; Heidenreich A; Salvioni R; Catanzaro M; Raggi D; Giannatempo P; Marandino L; Haidl F; Pederzoli F; Briganti A; Montorsi F; Chipollini J; Azizi M; De Meerleer G; Brouwer OR; Grass GD; Johnstone PA; Albersen M; Spiess PE; Necchi A
    Eur Urol Oncol; 2021 Oct; 4(5):802-810. PubMed ID: 33199252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy.
    Wei L; Li Z; Guo S; Ma H; Shi Y; An X; Huang K; Xiong L; Xue T; Zhang Z; Yao K; Luo J; Han H
    Cancer; 2024 May; 130(9):1650-1662. PubMed ID: 38157276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational Burden.
    Necchi A; Spiess PE; Costa de Padua T; Li R; Grivas P; Huang RSP; Lin DI; Danziger N; Ross JS; Jacob JM; Sager RA; Basnet A; Li G; Graf RP; Pavlick DC; Bratslavsky G
    JAMA Netw Open; 2023 Dec; 6(12):e2348002. PubMed ID: 38150257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and genotyping of human papillomavirus in a Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis.
    Ferrándiz-Pulido C; Masferrer E; de Torres I; Lloveras B; Hernandez-Losa J; Mojal S; Salvador C; Morote J; Ramon y Cajal S; Pujol RM; Garcia-Patos V; Toll A
    J Am Acad Dermatol; 2013 Jan; 68(1):73-82. PubMed ID: 22863066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
    Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
    BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune landscape and immunotherapy for penile cancer.
    Tang Y; Hu X; Wu K; Li X
    Front Immunol; 2022; 13():1055235. PubMed ID: 36524123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.
    Steinestel J; Al Ghazal A; Arndt A; Schnoeller TJ; Schrader AJ; Moeller P; Steinestel K
    BMC Cancer; 2015 Apr; 15():220. PubMed ID: 25885064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and penile cancer: recent developments and implications.
    Chahoud J; Pickering CR; Pettaway CA
    Curr Opin Urol; 2019 Jul; 29(4):364-370. PubMed ID: 31045928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines.
    Zhou QH; Deng CZ; Li ZS; Chen JP; Yao K; Huang KB; Liu TY; Liu ZW; Qin ZK; Zhou FJ; Huang W; Han H; Liu RY
    Cell Death Dis; 2018 Jun; 9(6):684. PubMed ID: 29880898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
    Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
    Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding genomics and the immune environment of penile cancer to improve therapy.
    Aydin AM; Chahoud J; Adashek JJ; Azizi M; Magliocco A; Ross JS; Necchi A; Spiess PE
    Nat Rev Urol; 2020 Oct; 17(10):555-570. PubMed ID: 32812000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Pathogenesis of Penile Squamous Cell Carcinoma: Current Understanding and Potential Treatment Implications.
    Keller BA; Pastukhova E; Lo B; Sekhon HS; Flood TA
    Arch Pathol Lab Med; 2023 Jun; 147(6):722-734. PubMed ID: 36136297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
    Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
    J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts.
    Lilja-Fischer JK; Ulhøi BP; Alsner J; Stougaard M; Thomsen MS; Busk M; Lassen P; Steiniche T; Nielsen VE; Overgaard J
    Acta Oncol; 2019 Oct; 58(10):1489-1494. PubMed ID: 31510843
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review.
    Ribera-Cortada I; Guerrero-Pineda J; Trias I; Veloza L; Garcia A; Marimon L; Diaz-Mercedes S; Alamo JR; Rodrigo-Calvo MT; Vega N; López Del Campo R; Parra-Medina R; Ajami T; Martínez A; Reig O; Ribal MJ; Corral-Molina JM; Jares P; Ordi J; Rakislova N
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
    Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
    Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.